Browsing by Author 787c1a22-2b62-4023-a6f3-52486d0e4e15
Showing results 1 to 1 of 1
Efficacy and safety of nilotinib 300mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift study
| Author(s) | Hiwase, Devendra; Tan, Peter; D'Rozario, James, et al |
|---|---|
| Type | Journal article |
| Date Published | 2018 |
| Date Created | - |
- previous
- 1
- next
Updated: 12 April 2016/ Responsible Officer: University Librarian/ Page Contact: Library Systems & Web Coordinator
+61 2 6125 5111
The Australian National University, Canberra
CRICOS Provider : 00120C
ABN : 52 234 063 906
